Regulatory Alerts2018-08-13
CMA Approves CIPLAQCL Prospectus
The Capital Markets Authority approved CIPLAQCL's prospectus, allowing the pharmaceutical company to issue 657,179,319 shares at UGX 256.5 each for listing on the Uganda Securities Exchange. This marks the ninth domestic Initial Public Offering on the exchange since 2012, providing the firm with new financing options and an exit avenue for founders. CMA CEO Keith Kalyegira urged other Ugandan businesses to consider market-based financing while advising investors to seek professional advice before participating in the offer.
Share